Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Sensitive Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03899467
What this trial is testing

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Suzhou Kintor Pharmaceutical Inc, 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT04126070
What this trial is testing

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Who this might be right for
Hormone Sensitive Prostate CancerProstate AdenocarcinomaMetastasis Prostate Adenocarcinoma
Xiao X. Wei, MD 47
Early research (Phase 1)Study completedNCT05868057
What this trial is testing

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

Who this might be right for
Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction
Jiangsu HengRui Medicine Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT02059213
What this trial is testing

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 72
Large-scale testing (Phase 3)Active Not RecruitingNCT04115007
What this trial is testing

Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients

Who this might be right for
Oligometastatic Hormone Sensitive Prostate Cancer
UNICANCER 550
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07268794
What this trial is testing

CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Cancer (Adenocarcinoma)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Fudan University 112
Testing effectiveness (Phase 2)Looking for participantsNCT05720130
What this trial is testing

Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
AdvanCell Pty Limited 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05241860
What this trial is testing

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
Alliance for Clinical Trials in Oncology 79
Not applicableNot Yet RecruitingNCT07031258
What this trial is testing

Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate CancerDarolutamide (DARO) in Combination With Androgen-deprivation Therapy (ADT) and Docetaxel (DOC)
Nanfang Hospital, Southern Medical University 50
Early research (Phase 1)Looking for participantsNCT06044025
What this trial is testing

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

Who this might be right for
Castration Sensitive Prostate Cancer
University of Arkansas 34
Large-scale testing (Phase 3)Study completedNCT04736199
What this trial is testing

Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bayer 669
Not applicableLooking for participantsNCT07172685
What this trial is testing

Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

Who this might be right for
Prostate Cancer
Qilu Hospital of Shandong University 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT03689699
What this trial is testing

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Mark Stein 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544830
What this trial is testing

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
PSA Level Greater Than TwoStage IV Prostate Adenocarcinoma AJCC v7
City of Hope Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT02058706
What this trial is testing

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
Barbara Ann Karmanos Cancer Institute 71
Very early researchActive Not RecruitingNCT03511196
What this trial is testing

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Who this might be right for
Prostate CancerStage IV Prostate CancerAdvanced Prostate Cancer+1 more
H. Lee Moffitt Cancer Center and Research Institute 17
Post-approval studies (Phase 4)Looking for participantsNCT05919329
What this trial is testing

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Who this might be right for
Castration Resistant Prostate CancerCastration Sensitive Prostate CancerProstate Adenocarcinoma
OHSU Knight Cancer Institute 80
Not applicableLooking for participantsNCT06446401
What this trial is testing

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Uppsala University 1,400
Early research (Phase 1)Study completedNCT04712396
What this trial is testing

Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Who this might be right for
Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)
AstraZeneca 11
Early research (Phase 1)Active Not RecruitingNCT06193993
What this trial is testing

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerMetastatic CancerHormone Sensitive Prostate Cancer+1 more
National University Hospital, Singapore 10
Next Page